13F
← All fund report cards

ARMISTICE CAPITAL, LLC

13F equity value
$3.0B
Positions
251
Top 10 concentration
32.5%
Quarters / total new picks
32 / 1,049
13F equity value over time
$0M$3B$6B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 37.5% of quarters (excess t = -0.61, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.0%
t-stat
-0.61
Quarterly win rate
38%
Annualized excess
-6.4%
$1 → follow vs universe
$1.29 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.22420180630: follow 1.08520180930: follow 1.04520181231: follow 1.09520190331: follow 1.06120190630: follow 1.16220190930: follow 1.26920191231: follow 1.13720200331: follow 1.24720200630: follow 1.31820200930: follow 1.64320201231: follow 1.61520210331: follow 1.63020210630: follow 1.71020210930: follow 1.42520211231: follow 1.04520220331: follow 1.02820220630: follow 0.90920220930: follow 1.04020221231: follow 1.09220230331: follow 1.06620230630: follow 0.94220230930: follow 1.12620231231: follow 1.13920240331: follow 1.13720240630: follow 1.17220240930: follow 1.20720241231: follow 1.07220250331: follow 1.13720250630: follow 1.18620250930: follow 1.28420251231: follow 1.289 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 251 · 2026 Q1

Ticker Value Weight QoQ
TVTX $146M
4.8%
ADD
PTCT $141M
4.7%
TRIM
MDGL $139M
4.6%
HOLD
SUPN $98M
3.2%
TRIM
NBIX $95M
3.1%
TRIM
AGIO $92M
3.0%
TRIM
IMVT $89M
2.9%
TRIM
FRPT $64M
2.1%
TRIM
INCY $62M
2.0%
TRIM
DYN $58M
1.9%
TRIM
AMZN $55M
1.8%
TRIM
IRWD $53M
1.7%
TRIM
CYTK $50M
1.7%
TRIM
HRMY $45M
1.5%
ADD
TMO $45M
1.5%
ADD
NKTR $42M
1.4%
TRIM
UNH $40M
1.3%
NEW
UBER $37M
1.2%
ADD
IMCR $36M
1.2%
ADD
XRAY $35M
1.1%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.